财务摘要（报告期）（Fennec Pharmaceuticals Inc）
| 2024年中报 | 2024年一季报 | 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 每股指标： | ||||||||||
| 每股收益EPS基本(元) | 0.27 | 0.47 | -0.60 | -0.50 | -0.43 | -0.23 | -0.90 | -0.65 | -0.34 | -0.14 |
| 每股净资产(元) | -0.05 | 0.11 | -0.43 | -0.40 | -0.37 | -0.28 | -0.10 | 0.11 | 0.33 | 0.48 |
| 每股经营现金净流量(元) | 1.12 | 1.44 | -0.63 | -0.46 | -0.36 | -0.21 | -0.69 | -0.43 | -0.24 | -0.11 |
| 每股现金流量净额(元) | 1.09 | 1.40 | -0.39 | -0.43 | -0.33 | -0.20 | 0.10 | 0.33 | -0.24 | -0.11 |
| 每股营业收入(元) | 1.19 | 0.94 | 0.79 | 0.43 | 0.19 | 0.06 | 0.06 | - | - | - |
| 盈利能力： | ||||||||||
| 销售毛利率(%) | 96.45 | 97.83 | 94.08 | 95.02 | 95.14 | 94.34 | 94.40 | - | - | - |
| 销售净利率(%) | 22.32 | 50.59 | -75.50 | -116.03 | -229.83 | -360.88 | -1,544.89 | - | - | - |
| 净资产收益率平均(%) | -112.24 | -298.26 | 226.13 | 204.02 | 186.99 | 122.16 | -359.22 | -181.51 | -72.13 | -26.12 |
| 总资产净利率(%) | 16.18 | 26.73 | -59.64 | -58.14 | -49.58 | -24.82 | -96.10 | -63.81 | -46.17 | -17.79 |
| 投入资本回报率ROIC(%) | 43.23 | 81.24 | -191.47 | -272.88 | -300.78 | -183.51 | -1,058.90 | -1,703.59 | -891.51 | -335.39 |
| 收益质量： | ||||||||||
| 营业利润／利润总额(%) | 119.49 | 107.06 | 79.59 | 81.97 | 86.43 | 87.08 | 95.26 | 97.61 | 97.57 | 95.94 |
| 经营活动产生的现金流量净额／营业收入(%) | 93.94 | 153.87 | -80.67 | -106.65 | -190.38 | -332.56 | -1,176.42 | - | - | - |
| 资本结构： | ||||||||||
| 资产负债率(%) | 102.15 | 95.64 | 143.26 | 155.34 | 150.04 | 133.63 | 109.54 | 90.79 | 45.14 | 34.60 |
| 权益乘数 | -46.54 | 22.96 | -2.31 | -1.81 | -2.00 | -2.97 | -10.49 | 10.86 | 1.82 | 1.53 |
| 产权比率 | -47.54 | 21.96 | -3.31 | -2.81 | -3.00 | -3.97 | -11.49 | 9.86 | 0.82 | 0.53 |
| 流动资产／总资产(%) | 98.43 | 98.52 | 99.98 | 99.57 | 99.45 | 99.27 | 99.22 | 99.13 | 99.91 | 99.89 |
| 非流动资产／总资产(%) | 1.57 | 1.48 | 0.02 | 0.43 | 0.55 | 0.73 | 0.78 | 0.87 | 0.09 | 0.11 |
| 流动负债／负债合计(%) | 12.01 | 14.86 | 19.63 | 13.24 | 12.95 | 13.79 | 15.62 | 10.60 | 43.22 | 32.24 |
| 非流动负债／负债合计(%) | 87.99 | 85.14 | 80.37 | 86.76 | 87.05 | 86.21 | 84.38 | 89.40 | 56.78 | 67.76 |
| 归属母公司股东的权益／投入资本(%) | -6.75 | 16.74 | -85.49 | -158.86 | -217.17 | -213.90 | -81.17 | 421.35 | 1,307.96 | 1,407.19 |
| 偿债能力： | ||||||||||
| 流动比率 | 8.02 | 6.93 | 3.56 | 4.84 | 5.12 | 5.39 | 5.80 | 10.30 | 5.12 | 8.96 |
| 速动比率 | 7.75 | 6.72 | 3.27 | 4.39 | 4.74 | 5.16 | 5.67 | 10.30 | 5.12 | 8.96 |
| 货币资金／流动负债(%) | 555.61 | 520.37 | 175.68 | 316.87 | 395.92 | 457.46 | 515.82 | 1,016.47 | 491.11 | 854.82 |
| 营业利润／流动负债(%) | 112.32 | 139.72 | -169.09 | -279.91 | -263.00 | -131.09 | -490.11 | -562.15 | -281.69 | -166.01 |
| 经营活动产生的现金流量净额／流动负债(%) | 395.66 | 396.98 | -226.97 | -313.90 | -252.06 | -138.73 | -391.80 | -384.56 | -205.66 | -133.71 |
| 归属母公司股东的权益／负债合计(%) | -2.10 | 4.55 | -30.20 | -35.63 | -33.35 | -25.17 | -8.71 | 10.15 | 121.55 | 189.04 |
| 经营活动产生的现金流量净额／负债合计(%) | 47.52 | 59.00 | -44.54 | -41.55 | -32.65 | -19.13 | -61.20 | -40.76 | -88.89 | -43.11 |
| 营业利润／负债合计(%) | 13.49 | 20.77 | -33.18 | -37.05 | -34.07 | -18.07 | -76.55 | -59.58 | -121.74 | -53.52 |
| 成长能力： | ||||||||||
| 总资产同比增长率(%) | 224.95 | 217.09 | -0.28 | -37.44 | 24.85 | 13.95 | 20.19 | 16.93 | -44.63 | -31.18 |
| 每股净资产同比增长率(%) | 86.47 | 140.02 | -341.25 | -470.27 | -211.99 | -157.78 | -116.07 | -85.39 | -61.76 | -49.84 |
| 总负债同比增长率(%) | 121.22 | 126.95 | 30.43 | 7.04 | 315.03 | 340.15 | 344.26 | 294.44 | 20.45 | 129.08 |
| 基本每股收益同比增长率(%) | 162.79 | 304.35 | 33.33 | 23.08 | -26.47 | -64.29 | -34.33 | -30.00 | - | 22.22 |
| 归属母公司股东的权益同比增长率(%) | 86.05 | 141.07 | -352.39 | -475.84 | -213.89 | -158.60 | -116.29 | -85.26 | -61.67 | -49.77 |
| 营业利润同比增长率(%) | 187.60 | 360.78 | 43.46 | 33.43 | -16.14 | -48.62 | -31.16 | -26.41 | 3.26 | 27.97 |
| 营业收入同比增长率(%) | 552.52 | 1,413.24 | 1,284.50 | - | - | - | - | - | - | - |
| 股东权益合计同比增长率(%) | 86.05 | 141.07 | -352.39 | -475.84 | -213.89 | -158.60 | -116.29 | -85.26 | -61.67 | -49.77 |
| 营运能力： | ||||||||||
| 存货周转率次(次) | 0.54 | 0.26 | 0.92 | 0.49 | 0.24 | 0.13 | 0.30 | - | - | - |
| 流动资产周转率次(次) | 0.73 | 0.53 | 0.79 | 0.50 | 0.22 | 0.07 | 0.06 | - | - | - |
| 总资产周转率次(次) | 0.73 | 0.53 | 0.79 | 0.50 | 0.22 | 0.07 | 0.06 | - | - | - |
| 衍生指标： | ||||||||||
| 现金及现金等价物净增加额TTM(元) | 28,096,000.00 | 32,794,000.00 | -10,505,000.00 | -17,353,000.00 | 43,000.00 | 131,000.00 | 2,674,000.00 | 5,417,000.00 | -12,378,000.00 | -8,492,000.00 |
| 利润总额TTM(元) | 2,735,000.00 | 2,844,000.00 | -16,045,000.00 | -20,220,000.00 | -26,442,000.00 | -26,070,000.00 | -23,714,000.00 | -21,284,000.00 | -17,380,000.00 | -16,309,000.00 |
| 毛利TTM(元) | 46,715,000.00 | 43,238,000.00 | 19,993,000.00 | 1,449,000.00 | 1,449,000.00 | 1,449,000.00 | 1,449,000.00 | - | - | - |
| 投入资本(元) | 20,107,000.00 | 18,009,000.00 | 13,595,000.00 | 6,629,000.00 | 4,479,000.00 | 3,431,000.00 | 3,165,000.00 | 665,000.00 | 653,000.00 | 890,000.00 |
| 经营活动产生的现金流量净额TTM(元) | 23,040,000.00 | 27,481,000.00 | -17,143,000.00 | -19,085,000.00 | -21,335,000.00 | -20,779,000.00 | -18,058,000.00 | -14,501,000.00 | -12,449,000.00 | -13,485,000.00 |
| 总营业收入TTM(元) | 48,889,000.00 | 44,952,000.00 | 21,252,000.00 | 1,535,000.00 | 1,535,000.00 | 1,535,000.00 | 1,535,000.00 | - | - | - |
| 归属母公司净利润TTM(元) | 2,735,000.00 | 2,844,000.00 | -16,045,000.00 | -20,220,000.00 | -26,442,000.00 | -26,070,000.00 | -23,714,000.00 | -21,284,000.00 | -17,380,000.00 | -16,309,000.00 |